We are live on ! Find out more
MM

MWG Management Portfolio holdings

AUM $81.3M
1-Year Est. Return 2.28%
This Fund
S&P 500
This Quarter Est. Return
+18.45%
1 Year Est. Return
+2.28%
3 Year Est. Return
-59.16%
5 Year Est. Return
-10.97%
10 Year Est. Return
AUM
$165M
AUM Growth
+$23.3M
Cap. Flow
-$610K
Cap. Flow %
-0.37%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PRME icon
Prime Medicine
PRME
+$610K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEAM icon
1
Beam Therapeutics
BEAM
$2.71B
$74.9M 45.33%
2,346,934
LYEL icon
2
Lyell Immunopharma
LYEL
$317M
$64.1M 38.79%
1,008,117
PRME icon
3
Prime Medicine
PRME
$551M
$26.3M 15.88%
1,792,210
-43,666
-2% -$610K

Similar funds

MWG Management's Q2 2023 Portfolio in Review

As of Q2 2023, MWG Management held 3 positions worth $165M, up 16% from $142M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 0%. MWG Management opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MWG Management's biggest Q2 2023 reduction was Prime Medicine, cutting an estimated $610K.
  • MWG Management's ten largest holdings make up 100% of its $165M portfolio in Q2 2023.
  • MWG Management opened 0 new positions and closed 0 in Q2 2023.
  • MWG Management's portfolio value rose 16% quarter-over-quarter to $165M.

Based on MWG Management's 13F filing for Q2 2023, filed 14 Aug 2023.